卡利克林相关酸酶的药物发现策略
Tobias Dreyer1, Daniela Schuster2,3, Viktor Magdolen1
1Department of Gynecology and Obstetrics, Technical University of Munich, 81675 Munich, Germany.
International journal of molecular sciences
|January 10, 2026
概括
与卡利克林相关的酶 (KLKs) 在健康和疾病,包括癌症中至关重要. 本综述探讨了包括人工智能在内的先进策略,以开发KLK抑制剂作为新疗法.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 卡利克林相关酶 (KLKs) 是哺乳动物中的重要酶,涉及生理过程和癌症等疾病.
- 前列腺特异性抗原 (PSA/KLK3) 是一个关键的KLK生物标志物和治疗点.
- 从历史上看,天然化合物一直是制药的丰富来源.
研究的目的:
- 审查开发针对KLKs的抑制剂的最先进策略.
- 突出计算方法和人工智能的作用,以加速 KLK 相关疾病的药物发现.
主要方法:
- 对当前药物发现技术的文献综述.
- 专注于基于结构的设计,高通量选和in silico方法.
- 考察KLK研究中的人工智能应用.
主要成果:
- KLKs是治疗干预的重要目标,因为它们与主要疾病有关.
- 基于结构的设计,HTS和虚拟选对于识别化合物是有效的.
- 人工智能对于生物科学中的快速药物发现越来越有价值.
结论:
- 先进的查和人工智能驱动的方法为开发新型KLK抑制剂提供了强大的工具.
- 准KLK对治疗各种癌症和其他疾病具有重大前景.
- 对KLK抑制剂的持续研究对于药物开发至关重要.
相关概念视频
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Protein-protein Interfaces
14.4K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
14.4K
Transducer Mechanism: Enzyme-Linked Receptors
3.8K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
3.8K


